Key PointsQuestionDo atropine, 0.01%, eyedrops slow the myopia progression and axial elongation when compared with a placebo group in Chinese children? FindingsIn this randomized clinical trial, atropine, 0.01%, eyedrops reduced myopia progression and axial elongation compared with placebo treatment after 1 year. MeaningWhile the clinical relevance of the results cannot be determined from this trial, these results support the potential that atropine, 0.01%, eyedrops can slow myopia progression in Chinese children and warrant future studies to determine longer-term results and potential effects on slowing sight-threatening pathologic changes later in life.
JAMA Ophthalmology – American Medical Association
Published: Nov 1, 2020